By activating GLP-1, tirzepatide sends signals of fullness to your brain, thereby helping you feel satisfied with smaller meals
Individual cardiac history, current medications, disease severity, and specific contraindications all factor into this clinical decision
In clinical trials , pediatric participants (aged 1217 years old) taking Saxenda were almost twice as likely to report pain in extremity than those taking a placebo
Based on FLOW, FDA approved Ozempic for the reduction of worsening kidney disease, kidney failure, and CV death in T2D + CKD patients on January 28, 2025 expanding the testing and biomarker monitoring requirements for Ozempic to include kidney function endpoints
Neither drugmaker provided any details about specific volumes